Litigation Details for Galderma Laboratories LP v. Actavis Laboratories UT Inc (N.D. Tex. 2017)
✉ Email this page to a colleague
Galderma Laboratories LP v. Actavis Laboratories UT Inc (N.D. Tex. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-04-21 |
| Court | District Court, N.D. Texas | Date Terminated | 2017-12-10 |
| Cause | 35:271 Patent Infringement | Assigned To | Barbara M. Lynn |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 8,815,816; 9,089,587; 9,233,117; 9,233,118; 9,782,425 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Galderma Laboratories LP v. Actavis Laboratories UT Inc
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Galderma Laboratories LP v. Actavis Laboratories UT Inc (N.D. Tex. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-04-21 | 1 | US Patent No. 8,362,069, # 2 Exhibit(s) B - US Patent No. 8,815,816, # 3 Exhibit(s) C - US Patent No.…9,089,587, # 4 Exhibit(s) D - US Patent No. 9,233,117, # 5 Exhibit(s) E - US Patent No. 9,233,118, # 6 Cover …2017 3:17-cv-01076 830 Property Rights: Patent Plaintiff District Court, N.D. Texas | External link to document | |
| 2017-11-16 | 60 | infringement of U.S. Patent Nos. 8,815,816 (the “‘816 Patent”); 9,089,587 (the “‘587 Patent”); 9,233,117 (“…“‘117 Patent”); 9,233,118 (the “‘118 Patent”); and U.S. Patent Nos. 8,362,069 (the “‘069 Patent”). The… claims of the ‘816 Patent, ‘587 Patent, ‘117 Patent, and ‘118 Patent are invalid…location of the patent holder is relevant to the patent venue analysis, and the patent venue statute does… seeks to add a related patent, U.S. Patent No. 9,782,425 (the “‘425 Patent”) that did not exist when | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
